Joshua Field, MD, MS is featured in an article published in the Milwaukee Journal Sentinel titled “New drug could ease pain of sickle cell disease”. The article focuses on Latoyia Webb, one of almost 100 participants in eight cities and one of 20 to 25...
The Models of Disease and Drug Discovery course covers the concepts involved in developing disease models in the laboratory, and using these model systems to identify candidate drugs that will eventually be developed for therapy in the clinic. Topics covered include current stem cell culture...
Fundamentals of Intellectual Property (20250A) addresses the principles of IP and presents best practices for protecting and managing IP rights in an academic research environment....
Purushottam W. “Prakash” Laud, PhD has been named Acting Director of the CTSI Biostatistics Program. Dr. Laud is the Acting Director of the Division of Biostatistics in the MCW Institute for Health and Society and Acting Director of the Biostatistics Shared Resource in the Cancer...
CTSI's Education and Training Program hosted a reception and research symposium to honor the 2011 - 2013 graduating cohort of Clinical Research Scholars and welcome the newly selected scholars. Over 80 people, including current and past scholars, program faculty, and members of the CTSI Board...
The National Center for Advancing Translational Sciences (NCATS) is announcing an open opportunity to submit proposals to collaborate with the Therapeutics for Rare and Neglected Diseases (TRND) program. The TRND program performs preclinical and early clinical development of new drugs for rare and neglected tropical diseases,...
